A pricey drug cuts cardiovascular risks in clinical trial — but will insurers cover it? – PBS NewsHour


PBS NewsHour

A pricey drug cuts cardiovascular risks in clinical trial — but will insurers cover it?
PBS NewsHour
A drug succeeded in lowering cardiovascular risks in a clinical trial, but questions remain over whether insurers will cover it. Photo by RunPhoto via Getty Images. A cholesterol-cutting drug from Amgen succeeded in lowering patients' risk of
Cholesterol drug prevents heart attacks — at $14000 a yearSarasota Herald-Tribune
Cholesterol drug cuts heart risks, spurs new debate on costKOKH FOX25
Cholesterol-slashing drug does not impair brain: studyYahoo News
NPR –FiercePharma –Business Insider –MedPage Today
all 121 news articles »

Comments

comments

You must be logged in to post a comment Login